| SPACE | Usual care | OR (95% CI) | |
| 12 months preceding randomisation | |||
| Respiratory admissions | 4 | 5 | 0.865 (0.225–3.327) |
| Nonrespiratory admissions | 6 | 11 | 0.590 (0.209–1.664) |
| 6 months post-randomisation | |||
| Antibiotic course | 82 | 70 | 1.199 (0.774–1.856) |
| Respiratory GP visits | 78 | 73 | 1.153 (0.749–1.775) |
| Respiratory GP home visits | 1 | 7 | 0.154 (0.019–1.279) |
| Respiratory nurse visits | 48 | 53 | 0.978 (0.601–1.590) |
| Respiratory specialist nurse home visits | 10 | 26 | 0.415 (0.189–0.910)* |
| Respiratory emergency department visits | 1 | 2 | 0.540 (0.048–6.058) |
| Respiratory admissions | 2 | 5 | 0.432 (0.082–2.283) |
| All cause admissions | 17 | 26 | 0.706 (0.359–1.389) |
Data are presented as n unless otherwise stated. GP: general practitioner. *: p<0.05.